Clinical Trials Directory

Trials / Completed

CompletedNCT01192425

Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

P06-001: (EX)Amination of (P)NH, by (L)Evel (O)f CD59 on (RE)d and White Blood Cells, in Bone Marrow Failure Syndromes

Status
Completed
Phase
—
Study type
Observational
Enrollment
5,580 (actual)
Sponsor
Alexion Pharmaceuticals, Inc. · Industry
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Conditions

Timeline

First posted
2010-09-01
Last updated
2010-09-01

Source: ClinicalTrials.gov record NCT01192425. Inclusion in this directory is not an endorsement.

Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes (NCT01192425) · Clinical Trials Directory